Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019

SELL
$39.26 - $54.21 $406,733 - $561,615
-10,360 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$29.84 - $43.92 $17,904 - $26,352
-600 Reduced 5.47%
10,360 $0
Q4 2018

Feb 14, 2019

BUY
$29.95 - $46.34 $23,960 - $37,072
800 Added 7.87%
10,960 $341,000
Q3 2018

Nov 19, 2018

SELL
$40.12 - $45.55 $10,030 - $11,387
-250 Reduced 2.4%
10,160 $0
Q1 2018

May 07, 2018

SELL
$39.4 - $47.39 $27,580 - $33,173
-700 Reduced 6.3%
10,410 $0
Q4 2017

Feb 12, 2018

SELL
$37.27 - $43.02 $22,362 - $25,812
-600 Reduced 5.12%
11,110 $0
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $395,212 - $487,955
11,710
11,710 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Paradigm Asset Management CO LLC Portfolio

Follow Paradigm Asset Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.